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Abstract
Background: Multi-walled carbon nanotubes (MWCNTs) constitute one of the most promising types of nanomaterials
in industry today. With their increasing use, the potential toxicity and carcinogenicity of MWCNT needs to be evaluated
in bioassay studies using rodents. Since humans are mainly exposed to MWCNT by inhalation, we performed a
104-week carcinogenicity study using whole-body inhalation exposure chambers with a fibrous straight type of
MWCNT at concentrations of 0, 0.02, 0.2, and 2 mg/m3 using male and female F344 rats.
Results: Lung carcinomas, mainly bronchiolo-alveolar carcinoma, and combined carcinomas and adenomas were
significantly increased in males exposed to 0.2 and 2 mg/m3 MWNT-7 and in females exposed to 2 mg/m3 MWNT-7
compared to the clean air control group. However, no development of pleural mesothelioma was observed.
Concentration-dependent toxic effects in the lung such as epithelial hyperplasia, granulomatous change, localized
fibrosis, and alteration in BALF parameters were found in MWNT-7 treatment groups of both sexes. There were no
MWNT-7-specific macroscopic findings in the other organs, including the pleura and peritoneum. Absolute and relative
lung weights were significantly elevated in male rats exposed to 0.2 and 2 mg/m3 MWNT-7 and in all exposed female
groups. The lung burdens of MWNT-7 were clearly increased in a concentration-dependent as well as a duration-
dependent manner.
Conclusion: There is clear evidence that MWNT-7 is carcinogenic to the lungs of male and female F344 rats,
however no plural mesothelioma was observed.
Keywords: Lung carcinoma, Lung carcinogenicity, Multi-walled carbon nanotube, MWCNT, MWNT-7, Inhalation
carcinogenicity, Whole body inhalation, Rat
Background
One of the most important developments in industrial
technology is nanotechnology. Various nanomaterials,
especially carbon nanotubes (CNTs), have exceptional
electrical, mechanical, and thermal properties, enabling
the commercialization of various types of CNTs for use
with numerous applications in industry, and in recent
years the production of CNTs has significantly increased
[1]. On the other hand, with the rapid growth of CNT
use, serious concerns have been expressed about their
adverse effects on the health of workers during CNT
manufacturing and handling processes and on the health
of consumers exposed to commercial end products
containing CNTs. At present, however, neither epi-
demiological nor medical case studies have been re-
ported on health consequences in CNT-exposed workers
or consumers.
Long, straight types of multi-walled carbon nanotube
(MWCNT) fibers, like asbestos, have a high aspect ratio
and are able to persist in biological tissues [2, 3]. The
“Stanton hypothesis” [4, 5], also known as the fiber para-
digm [6], asserts that fibers longer than 8 μm and less
than 0.25 μm in diameter have high carcinogenic poten-
tial. High aspect ratio fibers (especially fibers having
diameters less than 3 μm and lengths of greater than
5 μm, L/D ratio > 3) are thought to play an essential role
in the induction of intrathoracic tumors by fibrous
materials [2, 6–9]. Poland et al. reported that intraperi-
toneal administration in rodents of long, straight types
of asbestos or MWCNT fibers, but not nanoparticulate
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carbon black or short asbestos fibers or short or tangled
MWCNT, resulted in asbestos-like pathogenic responses
[10]. Thus, there is obvious reason for concern for pos-
sible asbestos-like health effects, such as induction of
pulmonary carcinoma and mesothelioma, by exposure
to fibrous MWCNTs. Importantly, Takagi et al. [11]
demonstrated that peritoneal mesotheliomas were in-
duced by intraperitoneal administration of one type of
fibrous MWCNT (MITSUI MWCNT-7, MWNT-7 in
the present study) to p53 knockout mice. Subsequently,
several studies reported that malignant mesotheliomas
developed in mice or rats after intraperitoneal or
intrascrotal administration of MWNT-7 [2, 12–14].
Thus, MWNT-7 is carcinogenic to the mesothelium
upon direct exposure.
MWCNT fibers are very light and easily become air-
borne, making inhalation the primary route of human
exposure [15, 16]. To assess the risk of MWCNT to ex-
posed workers, in vivo toxicity studies in rodents exposed
to MWCNT via inhalation are crucial. Ryman-Rasmussen
et al. [17] and Porter et al. [18] reported that MWCNT
inhaled by mice is toxic to lung and plural tissues, and
Sargent et al. [19] reported that inhalation of MWCNT at
5 mg/m3 for 15 days followed by a 17 month postexposure
period promoted methylcholanthrene initiated lung-
carcinogenesis in mice. Taken together, these results show
that airborne long straight MWCNT fibers are potentially
carcinogenic to mouse lung and pleural tissues.
We have developed a dry aerosol generation and ex-
posure system (cyclone sieve method) for whole-body
inhalation exposure to MWCNTs. Using this method,
we conducted 6-h, 2-week, and 13-week inhalation
studies of MWNT-7 using rats [20–22]. The results
revealed persistent inflammation and granulomatous
changes with multinucleated giant cells in the lung, a
concentration-dependent increase in the deposition of
MWNT-7 in the lung, and the presence of MWCNT-
containing alveolar macrophages. The concentration-
dependent increase in the retention of MWNT-7 in the
lung was associated with the severity of toxicity and
was particularly apparent in the 13-week study [22].
Importantly, MWNT-7 fibers were also observed in the
subpleural area and diaphragm. These results indicate
that inhaled MWNT-7 is deposited deep into the re-
spiratory tract and can be translocated into the pleural
cavity, and that exposure to MWNT-7 induces patho-
logical changes in the lung and chest cavity.
Taken together, the results of all of the studies cited
above led to the hypothesis that inhalation of MWNT-7
aerosol may result in tumor development in the lung
and possibly the pleura. Therefore, in order to clarify the
carcinogenicity of MWNT-7, we conducted a 2-year
carcinogenicity study of MWNT-7 by whole body inhal-
ation based on a widely accepted protocol [23]. In this
study, F344 male and female rats, 6-weeks-old at the
commencement of the study, were exposed to MWNT-7
aerosol for 6 h/day, 5 days/week for 104 weeks at con-
centrations of 0, 0.02, 0.2, and 2 mg/m3 using our dry
aerosol generation and exposure system.
Results
Environmental conditions of the inhalation chambers
All inhalation chambers were maintained at an air
exchange rate of 10 times/h (1668–1671 l/min), a
temperature of 22.9–23.0 °C, and a humidity of 52.7–
53.8 % during each exposure period (Table 1).
MWNT-7 concentrations and particle size distributions
MWNT-7 aerosols were freshly generated during each ex-
posure period, and the MWNT-7 concentrations in the
inhalation chambers were at the target doses throughout
the 104-week experimental period: 0.020 ± 0.001 (mean ±
SD) mg/m3 for the 0.02 mg/m3 group, 0.204 ± 0.014 mg/
m3 for the 0.2 mg/m3 group, and 2.018 ± 0.069 mg/m3 for
the 2 mg/m3 group. Figure 1a shows the concentrations of
the MWNT-7 aerosols in the inhalation chambers
throughout the experimental period. Mass median aero-
dynamic diameters (MMAD) and geometric standard de-
viations (GSD) of the MWNT-7 aerosol were in the range
of 1.2–1.4 μm and 2.6–3.0 in all MWNT-7-exposed
groups (Table 1). Scanning electron microscope (SEM) of
MWNT-7 collected on polycarbonate filters demonstrated
that most MWNT-7 s were single straight fibers and were
not aggregated, and no differences in MWNT-7 shape
were found between the three target concentrations in any
of the samples collected. Typical images of samples col-
lected on weeks 1 and 102 are shown in Fig. 1b and c.
Clinical observations, urinary, hematological and blood
biochemical analyses
Neither MWNT-7- related deaths nor clinical signs were
observed in any MWNT-7-exposed male or female ani-
mals during the 104-week experimental period. Survival
rates and body weight curves of male and female rats
from the MWNT-7 and control groups are shown in
Fig. 2. There were no differences between control and
exposure group survival rates of either male or female
rats; the survival rates exceeded 72 % and 68 % at the
end of 104-week experimental period for males and
females, respectively (Table 2). No growth retardation
was found in any of the male or female groups during
the experiment. The relative body weights of the 0.02,
0.2, and 2 mg/m3-exposed animals at the end of
experiment were 98, 102, and 100 % for males and 95,
100, and 94 % for females, respectively, compared to
their respective controls (Table 2).
Urinary, hematological, and blood biochemical analyses
revealed no toxicological changes in either male or female
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rats exposed to 0.02, 0.2, or 2 mg/m3 compared with their
respective controls (data not shown).
Macroscopic findings and organ weights
At the terminal necropsy, multiple grayish, white areas
and nodules were found in the lungs of a large number
of male and female rats exposed to 2 mg/m3 MWNT-7.
The color tone of the lung surface was darkened in line
with the exposure concentration (Fig. 3a and b). There
were no MWNT-7-specific macroscopic findings in the
other organs, including the pleura and peritoneum of
the animals that survived to the end of the experiment
or the animals that died or were sacrificed before the
end of the experiment.
Absolute and relative lung weights were significantly
elevated in male rats exposed to 0.2 and 2 mg/m3
MWNT-7, and they were significantly increased in all ex-
posed female groups (Table 2). No MWNT-7 exposure-
related increases were found in the other organs.
Microscopic findings
The results of histopathological examination of the
lungs, peritoneum and pleura are shown in Table 3.
The incidences of bronchiolo-alveolar carcinomas, total
carcinomas (bronchiolo-alveolar carcinomas, adenos-
quamous carcinoma, adenocarcinoma and squamous
cell carcinoma), and total carcinomas and/or adenomas
in males exposed to 0.2 and 2 mg/m3 MWNT-7 and fe-
males exposed to 2 mg/m3 MWNT-7 were significantly
increased compared with their respective control
groups. One adenosquamous carcinoma was found in
each of the 2 mg/m3-exposed male and female groups,
and one poorly differentiated adenocarcinoma and one
squamous cell carcinoma were found in the 2 mg/m3-
exposed female group; these malignant tumors very
rarely arise spontaneously: no such tumors were ob-
served in 599 control males or 600 control females in
previous 104-week inhalation carcinogenicity studies in
rats conducted by our institute during the last 10 years.
Most bronchiolo-alveolar tumors were single tumors,
while adenosquamous carcinoma, poorly differentiated
adenocarcinoma, and squamous cell carcinoma tended
to be multiple tumors. Tumor cells of the bronchiolo-
alveolar tumors destroyed the alveolar structure and
invaded the walls of bronchioles and blood vessels
(Fig. 3c). It was noteworthy that the MWNT-7-induced
bronchiolo-alveolar carcinomas were often accompan-
ied by proliferative fibrous connective tissue, which was
not present in the spontaneous lung carcinoma that de-
veloped in the control male rat (Fig. 3d).
No MWNT-7-related tumors were induced in the other
organs including the pleural and peritoneal mesothelium.
Incidences of bronchiolo-alveolar hyperplasia and al-
veolar hyperplasia were significantly increased in male
rats exposed to 0.2 and 2 mg/m3 MWNT-7 and in fe-
male rats exposed to 2 mg/m3 MWNT-7. Incidences of
bronchiolar hyperplasia and atypical hyperplasia were
significantly increased in male and female rats exposed
to 2 mg/m3 MWNT-7. Atypical hyperplasia consisted
of epithelial cells with atypia and was accompanied by
development of proliferative fibrous connective tissue
and alveolar macrophages with phagocytosed MWNT-7
(Fig. 3e). Alveolar hyperplasia was composed of local-
ized proliferation of type II alveolar epithelial cells,
Table 1 Characterization of chamber environment
Target concentration (mg/m3) 0 0.02 0.2 2
Temperature (°C) 23.0 ± 0.2 22.9 ± 0.1 23.0 ± 0.2 23.0 ± 0.2
Humidity (%) 53.8 ± 1.8 52.9 ± 2.4 53.3 ± 2.1 52.7 ± 2.0
Chamber air flow (L/min) 1670 ± 37 1671 ± 36 1671 ± 37 1668 ± 38
Mass concentration (mg/m3) a 0.000 ± 0.000 0.020 ± 0.001 0.204 ± 0.014 2.018 ± 0.069
MMAD (GSD): 1 week b - 1.3 μm (3.0) 1.4 μm (2.9) 1.3 μm (2.6)
MMAD (GSD): 14 week - 1.3 μm (2.8) 1.3 μm (2.9) 1.3 μm (2.9)
MMAD (GSD): 27 week - 1.3 μm (2.9) 1.3 μm (2.9) 1.3 μm (2.8)
MMAD (GSD): 40 week - 1.3 μm (2.9) 1.3 μm (2.9) 1.3 μm (2.9)
MMAD (GSD): 53 week - 1.4 μm (3.0) 1.4 μm (2.9) 1.4 μm (2.9)
MMAD (GSD): 66 week - 1.2 μm (2.9) 1.3 μm (2.9) 1.4 μm (2.8)
MMAD (GSD): 79 week - 1.3 μm (2.9) 1.3 μm (2.9) 1.4 μm (2.8)
MMAD (GSD): 92 week - 1.3 μm (3.0) 1.3 μm (3.0) 1.4 μm (2.8)
MMAD (GSD): 102 week - 1.4 μm (2.9) 1.3 μm (2.7) 1.3 μm (2.9)
Values indicates means ± SD
a The mass concentrations were calibrated from the particle concentration of MWNT-7 in the inhalation chamber measured by the OPC
b MMAD: Mass median aerodynamic diameter, GSD: geometric standard deviation
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accompanied by fractured alveolar macrophages in the
alveolar space. Bronchiolar hyperplasia was composed
mainly of proliferating ciliated columnar epithelial cells
in the terminal bronchiole area. Significantly elevated
incidences of granulomatous change and focal fibrosis
of the alveolar wall were noted in male and female rats
exposed to 0.2 and 2 mg/m3 MWNT-7. Focal fibrosis,
characterized by thickening and increased collagen
fibers, was often associated with the granulomatous
changes. Alveolar macrophages, with phagocytosed
MWNT-7 s accumulated in the alveolar spaces in male
and female rats exposed to 2 mg/m3 MWNT-7.
In the pleura, incidences of simple mesothelial hyper-
plasia of the parietal pleura (Fig. 3f ) and focal fibrosis
of the parietal pleura side of the diaphragm were






Fig. 1 a MWNT-7 concentrations in the inhalation chambers during the 104-week experimental period. Concentrations of MWNT-7 particles in
the inhalation chamber were monitored by the optical particle controller throughout each 6 h exposure period during the 104 weeks of the
study. Mass concentrations (mg/m3) of MWNT-7 in the chambers was calibrated by multiplying the CPM by the mass per particle (see Methods
for details). The target concentrations of MWNT-7 were 0.02, 0.2, and 2 mg/m3; panel A shows the measured concentrations of MWNT-7 aerosols
in the chambers. b and c SEM images of MWNT-7 in the inhalation chamber. SEM images of MWNT-7 in the chamber are shown in panels b and
c. The fibers shown in the figure were collected on a polycarbonate filter at 1-week and 102 weeks. The MWNT-7 aerosol was in the form of individual
and fibers in all groups. Bar, 5 μm
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Fig. 2 a, b Survival rates of rats exposed to MWNT-7 or clean air for 104 weeks. The survival rates of the rats are illustrated in panels A (male) and
B (female). The survival rate exceeded 72 % in males and 68 % in females at the end of the 104 weeks experimental period. There were no differences
in survival rates between the exposed and control groups. c, d Growth curves of rats exposed to MWNT-7 or clean air for 104 weeks. The
growth curves of the rats are illustrated in panels c (male) and d (female). Body weights were measured once a week for the first 14 weeks
and every 4 weeks thereafter. There was no growth retardation in any of the groups
Table 2 Absolute and relative, body weights and lung weights in rats exposed to MWNT-7 for 104 weeks
Male Female
Group (mg/m3) 0 0.02 0.2 2 0 0.02 0.2 2
Numbers of animals examined 50 50 50 50 50 50 50 50
Survival animal number 36 42 38 37 42 34 39 36
(rate:%) (72) (84) (76) (74) (84) (68) (78) (72)
Body weight
Terminal body weight (g) mean 401 394 410 399 278 265 277 261 *
SD 45 37 39 38 31 26 23 26
Relative body weight (%) mean 100 98 102 100 100 95 100 94
Lung weight
Terminal lung weight (g) mean 1.31 1.34 1.51 ** 2.37 ** 0.90 0.94 ** 1.14 ** 1.87 **
SD 0.10 0.12 0.13 0.31 0.21 0.10 0.27 0.18
Relative lung weight (%) mean 0.36 0.37 0.40 ** 0.65 ** 0.35 0.38 ** 0.45 ** 0.79 **
SD 0.06 0.05 0.06 0.20 0.10 0.05 0.14 0.16
Terminal body weight (g): Absolute body weight at the end of 104 weeks
Relative body weight (%): Percentage of the body weight in the control group
Terminal lung weight (g): Absolute lung weight at the end of 104 weeks
Relative lung weight (%): Percentage of the terminal lung weight in each animal’s body weight
Significant difference; *: p≦0.05 **: p≦0.01 by Dunnett’s Test
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In female rats exposed to 2 mg/m3 MWNT-7, there
was a non-significant increase in the incidences of
simple mesothelial hyperplasia and focal fibrosis of the
parietal pleura. The incidence of focal fibrosis of the
ventral pleura was elevated in male and female rats
exposed to 2 mg/m3 MWNT-7. Finally, the incidence
of inflammation of the mediastinum was elevated in
male rats exposed to 2 mg/m3 MWNT-7.
Goblet cell hyperplasia was also observed in the frontal
respiratory epithelium of the nasal cavity and nasophar-
ynx of male and female rats exposed to 0.2 and 2 mg/m3
MWNT-7 and in the respiratory epithelium of the naso-
pharynx of female rats exposed to 0.02 mg/m3 MWNT-
7. Incidences of eosinophilic globules, which appeared in
the cytoplasm of the respiratory and olfactory epithelia
in the nasal cavity, were increased in male and female
rats exposed to 0.2 and 2 mg/m3 MWNT-7. Eosinophilic
globules could be the normal reaction to mild irritation
[24]. No remarkable non-neoplastic changes were found
in the other organs.
Microscopically, single or aggregated MWNT-7 s
were found in the nasal cavity, larynx, trachea, lungs,
lymph nodes, spleen, liver, kidneys, olfactory bulb, and
brain of the exposed rats of both sexes. MWNT-7
fibers in the kidney, olfactory bulb, and brain were
single and not aggregated. The degree of MWNT-7
deposition in the lungs and mediastinal lymph nodes




Fig. 3 Macroscopic and microscopic findings of the lungs and peritoneal pleura. a Lung from a control male rat. b Multiple white areas and
nodules in the lungs of a 2 mg/m3 MWNT-7-exposed male. c Bronchiolo-alveolar carcinoma in the lung of the male rat exposed to 2 mg/m3
MWNT-7. Carcinoma cells invaded the wall of the vein. Bar, 50 μm. d Bronchiolo-alveolar carcinoma in the lung of a female rat exposed to 2 mg/
m3 MWNT-7. Proliferation of carcinoma cells accompanied by fibrous connective tissue is causing the disappearance of the existing alveolar
construction. Bar, 50 μm. e Atypical hyperplasia accompanied by proliferative fibrous connective tissue and MWNT-7 deposition in the lung of a
female rat exposed to 2 mg/m3 MWNT-7. Epithelial cell polarity is poorly defined and the nuclei of the cells vary in size. Bar, 30 μm. f The left
image shows the normal parietal pleura of a control male rat. The right image shows a simple mesothelial hyperplasia of the parietal pleura in a
male rat exposed to 2 mg/m3 MWNT-7. Bar, 25 μm
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observed by light microscopy outside of the lungs and
mediastinal lymph nodes.
Cytological and biochemical analyses of bronchoalveolar
lavage fluid (BALF)
The numbers of neutrophils, eosinophils, lymphocytes,
and macrophages were increased in the BALF of males
and females concentration-dependently and neutrophils,
eosinophils, and lymphocytes were significantly elevated
in 2 mg/m3 MWNT-7 exposed males and females, and
macrophages were also significantly higher in 2 mg/m3
MWNT-7 exposed females (Fig. 4a). ALP, LDH, and
total protein levels were also elevated in the BALF of
males and females concentration-dependently and were
significantly elevated in males and females exposed to
0.2 and 2 mg/m3 MWNT-7 (Fig. 4b).
MWNT-7 lung burden
Figure 5 shows the MWNT-7 lung burden of the rats
that were euthanized or died before the end of the 104-
week experimental period. The amount of retained
MWNT-7 was related to the MWNT-7 concentration
and overall exposure time. The results of the lung bur-
den analysis of MWNT-7 at the end of exposure period
are presented in Fig. 6. Amounts of MWNT-7 in the
lungs increased linearly with concentration in both
males and females (Fig. 6a). The relative amounts of
MWNT-7 per body weight were similar between the
Table 3 Histopathological findings of the lung, peritoneum and pleura in rats exposed to MWNT-7 for 104 weeks
Male Peto test Female Peto test
Group (mg/m3) 0 0.02 0.2 2 0 0.02 0.2 2
Number of animals examined 50 50 50 50 50 50 50 50
Neoplastic lesions
Lung
Bronchiolo-alveolar carcinoma 1 1 8 # 10 ## ↑↑ 0 1 0 5 ## ↑↑
Adenosquamous carcinoma 0 0 0 1 0 0 0 1
Poorly differentiated adenocarcinoma 0 0 0 0 0 0 0 1
Squamous carcinoma 0 0 0 0 0 0 0 1
Total carcinoma 1 1 8 # 11 ## ↑↑ 0 1 0 8 ## ↑↑
Bronchiolo-alveolar adenoma 1 1 7 # 5 3 1 4 3
Total adenoma and/or carcinoma 2 2 13 ## 16 ## ↑↑ 3 2 4 11 # ↑↑
Peritoneum
Malignant mesothelioma 0 3 1 1 0 0 0 0
Non-neoplastic lesions
Lung
Bronchiolo-alveolar hyperplasia 2 (1.5) 6 (1.3) 13 * (1.2) 22 ** (1.0) 3 (1.3) 3 (1.0) 8 (1.1) 12 * (1.1)
Atypical hyperplasia 0 0 1 (1.0) 10 ** (1.3) 0 0 0 14 ** (1.1)
Alveolar hyperplasia 0 2 (1.0) 13 ** (1.0) 41 ** (1.0) 1 (1.0) 1 (1.0) 6 (1.0) 41 ** (1.1)
Bronchiolar hyperplasia 0 0 4 (1.0) 8 ** (1.0) 0 (1.0) 0 (1.0) 4 (1.0) 26 ** (1.0)
Accumulation: alveolar macrophage 2 (1.0) 7 (1.0) 5 (1.0) 48 ** (2.0) 2 (1.0) 6 (1.0) 9 (1.0) 48 ** (1.8)
Focal fibrosis: alveolar wall 0 2 (1.0) 43 ** (1.0) 48 ** (1.8) 0 3 (1.0) 44 ** (1.0) 49 ** (1.2)
Granulomatous change 0 5 (1.0) 42 ** (1.0) 50 ** (1.9) 0 3 (1.0) 45 ** (1.0) 50 ** (1.8)
Pleura
Simple mesothelial hyperplasia 3 (1.0) 3 (1.0) 7 (1.0) 12 * (1.0) 3 (1.0) 2 (1.0) 6 (1.0) 10 (1.0)
Focal fibrosis: parietal (diaphragm) 0 0 2 (1.0) 6 * (1.0) 0 0 0 3 (1.0)
Focal fibrosis: ventral (lung) 0 (1.0) 2 (1.0) 4 (1.0) 19 ** (1.1) 0 2 (1.0) 2 (1.0) 20 ** (1.0)
Inflammation: mediastinum 15 (1.0) 18 (1.0) 21 (1.0) 26 * (1.0) 17 (1.0) 17 (1.0) 16 (1.0) 19 (1.0)
Inflammation: diaphragm 0 0 1 (1.0) 1 (1.0) 0 1 (1.0) 1 (1.0) 1 (1.0)
Values indicate number of animals bearing the lesion
Values in parentheses are the average of severity grade indexes of the lesions in affected animals. The average of severity grade indexes are calculated with a
following equation. 〔Σ(grade × number of animals with grade)〕÷number of affected animals. Grade: 1 = slight, 2 = moderate, 3 = marked, 4 = severe
Significant difference; *: p≦0.05, **: p≦0.01 by Chi-square Test, #: p≦0.05, ##: p≦0.01 by Fisher Exact Test, ↑: p≦0.05, ↑↑: p≦0.01 by Peto’s Test
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males and females in the different exposure groups
(Fig. 6b).
A summary of the incidence of lung carcinoma and
the lung burden of MWNT-7 in the exposed groups at
the end of the 104-week experimental period is given in
Table 4. One μg of MWNT-7 was determined to equal
9.03 × 106 MWNT-7 fibers by SEM examination. The
numbers of MWNT-7 fibers in the lungs of each expos-
ure group was calculated based on this number of
MWNT-7 fibers per μg and the result of the lung
burden analysis. The number of MWNT-7 fibers in the
lung increased in a concentration dependent manner
(Table 4). The number of fibers per body weight were
similar between males and females in the different con-
centration groups. The number of fibers that induced
lung carcinoma was calculated to be 1.38 × 109 MWNT-
7 fibers in 0.2 mg/m3 MWNT-7 exposed males and
10.4 × 109 MWNT-7 fibers in 2 mg/m3 MWNT-7 ex-
posed females. The number of fibers per gram body
weight that induced lung carcinoma was calculated to be
3.92 × 106 MWNT-7 fibers/gram body weight in males
and 42.5 × 106 MWNT-7 fibers/gram body weight in
females.
Observation of MWNT-7 in the lung
To observe MWNT-7 in the lung, lung tissues were
digested, and specimens were observed by SEM. Alveo-
lar macrophages which were digested completely or in-
completely were obtained from lung tissues. Figure 7a
is an incompletely digested macrophage phagocytosing
MWNT-7, while Fig. 7b shows a completely digested
macrophage. Figure 7b shows a cocoon-like mass ap-
proximately 12 μm in diameter formed by MWNT-7
fibers. The fibers in these masses wound around each
other to form a dense aggregate. The size of the
MWNT-7 masses was approximately 10–20 μm in
diameter, and the number of the masses present in the
lungs increased concentration-dependently (data not
shown). These large aggregates of MWNT-7 fibers
came from alveolar macrophages, because MWNT-7
Fig. 4 Cytological and biochemical analyses of bronchoalveolar lavage fluid (BALF). a Cytological analyses. Total cells per 1 ml in the BALF is
shown. There is a concentration-dependent increase in the numbers of inflammatory cells, and the numbers of eosinophils, lymphocytes, neutrophils,
and macrophages in the males and females exposed to 2 mg/m3 MWNT-7 are significantly increased. **: p < 0.01 by Dunnett’s multiple comparison
test. b Biochemical analyses: Total protein (Tp), Lactate dehydrogenase (LDH), and alkaline phosphatase (ALP) levels in the BALF were determined for
male and female rats. Error bars indicate the SD for 5 rats. Tp, LDH, and ALP are significantly increased in a concentration-dependent manner in males
and females. *: p < 0.05 and **: p < 0.01 by Dunnett’s multiple comparison test
Kasai et al. Particle and Fibre Toxicology  (2016) 13:53 Page 8 of 19
aggregates were also observed in incompletely digested
alveolar macrophages. Importantly, these aggregates of
MWNT-7 fibers were not observed in the MWNT-7
aerosols in any of the inhalation chambers.
Measurement of the number MWNT-7 in pleural and ab-
dominal lavage fluid
MWNT-7 fibers were present in pleural and abdominal
lavage fluid. The number of MWNT-7 fibers in the
pleural area were 38, 134, and 1468 fibers in the 0.02,
0.2, and 2 mg/m3 exposed males and 23, 240, and 847
fibers in the 0.02, 0.2, and 2 mg/m3 exposed females.
The number of MWNT-7 fibers in the abdominal area
were 16, 161, and 2429 fibers in the 0.02, 0.2, and 2 mg/
m3 exposed males and 34, 294, and 3329 fibers in the
0.02, 0.2, and 2 mg/m3 exposed females. SEM examin-
ation revealed that in the pleural and the abdominal lav-
age fluid the MWNT-7 were individual, long, straight
fibers and not aggregated (Fig. 7c and d).
Discussion
To test for potential hazard to humans of airborne
straight, fibrous MWCNT, rats were exposed to MWNT-
7 aerosol for 6 h/day, 5 days/week for 104 weeks. Airborne
MWNT-7 showed clear lung carcinogenicity.
Exposure to MWNT-7 aerosol for 104 weeks was
found to cause statistically significant increases in the
incidences of lung carcinomas and combined adenomas
and carcinomas in males exposed to 0.2 and 2 mg/m3
MWNT-7 and in females exposed to 2 mg/m3 MWNT-
7. The increased incidence of lung carcinomas and com-
bined adenomas and carcinomas in males was clearly
does-dependent. In both males and females, the lung
carcinomas were mainly bronchiolo-alveolar carcinomas.
In addition to bronchiolo-alveolar carcinomas, adenos-
quamous carcinomas, a squamous cell carcinoma, and a
poorly differentiated adenocarcinoma were found in 1
male and 3 female rats exposed to 2 mg/m3 MWNT-7;
these carcinomas very seldom develop spontaneously
and are thus likely to be linked to MWNT-7 exposure.
In addition, pre-neoplastic lesions (bronchiolo-alveolar
hyperplasia and atypical hyperplasia [25, 26]) and reactive
hyperplasia (alveolar hyperplasia and bronchial hyper-
plasia [25, 27]) in the lungs of male and female rats were
significantly increased in a concentration-dependent man-
ner. These results are consistent with the development of
lung carcinoma.
In the present study, there were no abnormal clinical
signs, suppression of body weight gain or delay of growth
rate, or decreased survival rate in the exposed groups.
Therefore, the highest exposure concentration, 2 mg/m3
Fig. 5 Results of lung burden analysis. MWNT-7 fibers in the lung were measured for rats that died or were sacrificed in a moribund condition before
the end of the experiment. The lung burden increased with concentration and time of exposure
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MWNT-7, fulfills the maximum tolerated dose (MTD)
criteria [28, 29] for 104-week bioassay studies of rodent
carcinogenicity: the highest dose of the carcinogenicity
study should not alter the animals’ normal longevity from
toxic effects other than carcinogenicity, and there should
be no more than a 10 % weight decrement compared to
the concurrent controls.
The fiber paradigm theorizes that longer fibers exert
stronger toxic and carcinogenic effects than shorter ones
because alveolar macrophages are unable to completely
take up longer fibers [30]. In support of this theory,
Muller et al. [31] reported that no mesotheliomas were
observed in Wistar rats after intraperitoneal injection of
MWCNT of average length less than 1 μm. Our results















0 2 - - - -
0.02 2 10.0 0.09 × 109 0.029 0.26 × 106
0.2 16 * 152.4 1.38 × 109 0.434 3.92 × 106
2 22 ** 1797.8 16.2 × 109 4.954 44.7 × 106
Female
0 0 - - - -
0.02 2 8.1 0.07 × 109 0.034 0.31 × 106
0.2 0 118.4 1.07 × 109 0.453 4.09 × 106
2 16 ** 1154.1 10.4 × 109 4.712 42.5 × 106
Number of MWNT-7: 1ug = 9.03 × 106 (calculated by SEM)
Significant difference; *: p≦0.05 **: p≦0.01 by Fisher Exact test
Fig. 6 Results of lung burden analysis in rats at 104 weeks. The lung burdens of 10 rats from each exposure group were measured. a Total
amounts of MWNT-7 (μg) in whole lungs in male and female rats is plotted against the exposure concentration. The amount of MWNT-7 in the
lungs increased linearly in a concentration-dependent manner. b The relative amount of MWNT-7 (μg/body weight) in the lungs of male and
female rats. The relative amounts of MWNT-7 found in the lungs are the same in males and females
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support this length hypothesis: the mean length of
MWNT-7 collected from the lungs of exposed rats in
the present study was 5.8–5.9 μm.
In the present inhalation study, the number of
MWNT-7 fibers in the lung needed for inducing lung
carcinoma was over 1 × 109 fibers. Rittinghausen et al.
[2] reported intraperitoneal injection of 1 × 109 or 5 ×
109 MWCNT fibers resulted in tumor incidences of 40
and 100 %, respectively. These two results suggest that
large amounts of MWCNT are needed to induce the de-
velopment of malignant tumors.
Total lung burden (Deposited lung dose) is calculated as
Exposure concentration ×Minute ventilation × Exposure
duration ×Alveolar deposition fraction. The MWNT-7
deposited in the lungs of male rats exposed to 0.02, 0.2,
and 2 mg/m3 MWNT-7 resulted in total lung burdens of
approximately 0.01, 0.15, and 1.8 mg (Table 4), respect-
ively. Using an average minute ventilation for male rats of
186 ml/min [32] and an exposure duration of 6 h/day ×
492 days, the deposition fraction was calculated as roughly
1.5–2.7 %.
To begin to assess possible effects of human exposure to
MWNT-7 in the workplace, we calculated the correlation
of rodent to human exposure in accordance with the
report of Kuempel and Erdely [33, 34]: Human lung
burden equals rat lung burden (0.01, 0.15, and 1.8 mg) ×
Human alveolar surface area (102 m2) / rat alveolar
surface area (0.4 m2), resulting in approximate equiva-
lent whole lung burdens of 2.6, 38.3, and 459 mg in
humans. Assuming (1) human ventilation is 20 L/min
during light work, (2) exposure for 8 h per day, 5 days
per week, 52 weeks per year, over a working lifetime of
45 years, and (3) a deposition efficiency of 4 %, then
lung burdens of 2.6, 38.3, and 459 mg in humans would
require that workers are exposed to concentrations of
0.6, 8.5, and 102.2 μg/m3 MWNT-7: human lung bur-
den equals (airborne MWNT-7 concentration) × (20 L/
min × 10-3 m3/L × 60 min /h × 8 h/d × 5 d/week × 52
weeks/year × 45 years) × 4 %. Of note, a worker exposed
to a concentration of 8.5 μg/m3 can expect an approxi-
mate lung deposition of 38.3 mg, which is equivalent to
a lung burden of 150 μg in rats, a lung burden that re-
sulted in development of lung carcinoma in male rats.
Values of 0.6, 8.5, and 102.2 μg/m3 are within the range
of reported workplace exposures with measured total
gravimetric mass concentrations of MWCNT ranging
Fig. 7 SEM image of alveolar macrophages and MWNT-7 in the lung, and MWNT-7 in the pleural or abdominal fluid. a An incompletely digestion
alveolar macrophage from the lung of a male rat exposed to 0.02 mg/m3 MWNT-7. b After complete digestion of macrophages, large cocoon-like
masses of fibers were observed. The spacemen was collected from the lung of a male rat exposed to 0.02 mg/m3 MWNT-7. c MWNT-7 from the pleural
fluid. The morphology of the MWNT-7 fiber is single and straight. d MWNT-7 from the abdominal fluid. The morphology of the MWNT-7 fiber is single
and straight
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from 0.7 to 332 μg/m3 in personal breathing zones
[35–37].
The amount of MWNT-7 retained in the lungs
increased with concentration, and the development of
pre-neoplastic and neoplastic lesions in the lungs also
increased with concentration. This is consistent with
the premise that biopersistence is an important factor
in fiber-dependent generation of neoplasias [30]. This
may also explain the requirement for the large amounts
of MWCNT that are needed to induce the development
of malignant tumors.
In our previous study, we observed large aggregates
of MWNT-7 in alveolar macrophages [21, 22], and in
the present study large aggregates of MWNT-7 were
also observed in digested alveolar macrophages. These
aggregates were composed of MWNT-7 fibers that
wound around each other forming large dense cocoon-
like shaped masses approximately 10–20 μm in diam-
eter (Fig. 7b). The formation of these masses is most
likely due to the structural flexibility of MWNT-7.
There was a concentration-dependent increase in the
number of these masses in the lung tissue. The increase
of undigested MWNT-7 s with increased exposure time
demonstrates the possibility of a continuous, extended
reaction against these fibers: the persistence of phago-
cytosed indigestable materials have been reported to be
associated with production of high levels of ROS and
inflammatory cytokines [38–41]. In addition, Donaldson
et al. [30] reported that frustrated phagocytosis by macro-
phages attempting to enclose long fibers leads to pro-
longed release of cytokines and oxidants.
The presence of large aggregates of MWNT-7 fibers
in alveolar macrophages is likely to be a source of intra-
cellular stress, even if they do not explicitly demonstrate
incomplete phagocytosis (Fig. 7b). Fractured alveolar
macrophages in the proximal alveolar space were also
found in the present study. Our results suggest that not
only the length but also the quantity of MWNT-7 fibers
is important in the pulmonary toxicity of MWNT-7.
Overall, our results support the paradigm that bioper-
sistence of fibers such as MWNT-7 leads to persistent
generation of oxidants and cytokines, which in turn
leads to continuous inflammation, and that inflamma-
tion can lead to the development of hyperplastic lesions
(Table 3) that have the potential to develop into malig-
nant tumors (Table 3).
There was a gender difference in the development of
pre-neoplastic and neoplastic lesions in MWNT-7-
exposed rats: exposure to 0.2 mg/m3 MWNT-7 resulted
in development of lung tumors in males but not females.
The lung weights of the males and females were 1.51 and
1.14 g, respectively (Table 2), and the number of MWNT-
7 fibers in the whole lung of males and females exposed to
0.2 mg/m3 MWNT-7 was 1.38 × 109 and 1.07 × 109 fibers,
respectively (Table 4). Consequently, the number of
MWNT-7 fibers per lung weight (g) in males and females
was 0.91 × 109 and 0.94 × 109, respectively. These results
indicate that there was not a relationship between the
number of fibers per gram of lung and the gender differ-
ence in tumor development in the present study. How-
ever, the historical control data our institute has complied
from the control groups of inhalation carcinogenicity
studies conducted over the past 10 years, shows that the
incidence of spontaneous bronchiolo-alveolar tumors in
F344 rats is higher in males than in females (bronchiolo-
alveolar adenoma: 35/599 males and 14/600 females,
bronchiolo-alveolar carcinoma: 6/599 males and 0/550
females). Therefore, the difference in the sensitivity be-
tween males and females exposed to MWNT-7 is likely to
be due to gender differences in their basic susceptibility to
the development of lung tumors.
Sargent et al. [19] reported that MWNT-7 inhalation ex-
posure at 5 mg/m3 for 15 days using mice pretreated with
methylcholanthrene (a tumor initiator) increased inci-
dences of bronchiolo-alveolar tumors in the lungs at
17 months post-exposure. However, exposure of MWNT-
7 without an initiator did not increase the incidences of
lung tumors in their study. Consequently, they concluded
that MWNT-7 s have a promoter effect in mouse lung
carcinogenesis. In contrast, in our study, exposure of rats
to MWNT-7 for 104 weeks without a tumor initiator in-
duced development of lung carcinomas. These two results
suggest that not only amounts of MWNT-7 but also ex-
posure duration have important roles in lung carcinogen-
esis mediated by MWNT-7. Additionally, it is likely that
the mouse is less susceptible to particle induced carcino-
genesis than the rat, as previous investigations of rodent
exposure have shown that exposure to asbestos by inhal-
ation or intratracheal instillation is strongly carcinogenic
in the rat lung but only weakly carcinogenic in the mouse
[42–44].
There was no induction of pleural mesothelioma, how-
ever, there was a concentration-dependent increase of pro-
liferative lesions, such as mesothelial hyperplasia in the
parietal pleura, in both males and females. Notably, the
number of MWNT-7 fibers in the pleura of the 2 mg/m3-
MWNT-7 exposed groups was 1 × 103 fibers, 106 fold
lower than the number of fibers needed to result in tumor
formation in the lung. The considerable difference in fiber
number between the lung and the pleura likely accounts
for the difference in tumor induction in these organs.
Recently it was reported that pleural mesotheliomas were
induced in rats administered MWCNT (NIKKISO, Tokyo,
Japan) at a dose of 1 mg over a 2-week period by intratra-
cheal instillation and then followed for 2 years without any
treatment [45]. Further studies are required to determine
the reason for the different results obtained from adminis-
tration using inhalation and intratracheal instillation.
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Straight MWCNT fibers and asbestos are thought to
have similar physical characteristics, such as a long and
thin form (i.e., high aspect ratio) and high mechanical
strength, although the chemical surface properties are
different. Male rats exposed to asbestos by inhalation
developed lung tumors and mesothelioma [46, 47].
Histopathological classification of the lung tumors were
adenoma, adenocarcinoma, squamous cell carcinoma,
and unclassified lung carcinoma. Biopersistence of as-
bestos fibers is a primary factor in the toxic effects
exerted by asbestos [30, 48]. The results of asbestos
studies and our study point to a similarity between
MWNT-7 and asbestos hazard, supporting previous
predictions of the risk of MWCNT fibers to exposed
humans [30].
The determination of whether a genotoxic or non-
genotoxic mechanism operates in MWNT-7 induced
carcinogenicity is important for carcinogen risk assess-
ment. In an in vitro study, Ames tests of MWNT-7
were negative, indicating that MWNT-7 is not a direct
DNA mutagen [49]. In contrast, using eukaryotic cells
positive results for MWNT-7 genotoxicity were ob-
tained: Ema et al. [49] and Asakura et al. [50] reported
that MWNT-7 genotoxicity was characterized by for-
mation of polyploidy without structural chromosomal
aberration; Asakura et al. [50] reported increased numbers
of bi- and multi-nucleated cells without micronucleus in-
duction; Yasui et al. [51] observed that comparatively long
MWNT-7 (approximately ≥ 20 μm) inhibited cytokinesis
during cell division and induced the formation of binu-
cleated cells, whereas short MWNT-7 did not. Interest-
ingly, Kato et al. [52] reported that MWNT-7 induced
micronucleus formation and sister chromatid exchange.
Taken together, these results indicate that MWNT-7
does not induce mutations through direct interaction
with the DNA (negative results in Ames tests) but ra-
ther through direct interference with biological pro-
cesses during cytokinesis. In addition, Kato et al. [52]
report that intratracheal instillation of MWNT-7 in
mice increased gpt mutation frequencies, DNA damage
by comet assay, and DNA oxidative damage. This type
of damage is consistent with damage due to oxidative
stress and inflammatory responses, but gpt mutations
and oxidative damage are not consistent with aberrant
cytokinesis. Therefore, these results suggest that the
genotoxicity of MWNT-7 in vivo is due to secondary
mechanisms such as oxidative stress and inflammatory
responses.
Because of the differences in fiber length, shape, and
rigidity of different MWCNTs, factors that are likely to
be crucial in the development of tumors, the present
study does not apply to all MWCNTs. However, based
on MWNT-7, a fibrous MWCNT, having a carcinogenic
potential, it is important to consider the risk to humans
of exposure to rigid MWCNTs with a similar length and
width.
Based on animal experimental studies, IARC [53] evalu-
ated MWNT-7 as being a possible carcinogen to humans
(Group 2B). NIOSH (2013) [54] proposed an 8-h time-
weighted average concentration of 1 μg/m3 as the Recom-
mended Exposure Limit (REL) for the respirable mass
fraction of elemental carbon, single or multi-walled car-
bon nanotubes, and carbon nanofibers.
For risk analysis, a point of departure (PoD) from the
observed carcinogenesis data should be estimated to
mark the beginning of extrapolation to lower doses. The
lower confidence limits of the benchmark dose yielding
a response with a 10 % extra risk (BMCL10) were calcu-
lated with US.EPA’s benchmark dose software Version
2.6 (US.EPA, 2015) [55]. In the present study, induction
of lung carcinoma in male rats was observed at 0.2 mg/
m3 MWNT-7 and the BMCL10 of adverse effect in
exposed male rats was calculated to be 0.01 mg/m3.
MWNT-7 is classified as a genotoxicic substance but
not directively DNA-reactive [49–52], and it has been
accepted that there are thresholds for carcinogens that
induce mutations via secondary genotoxic mechanisms
[56, 57]. Consequently, MWNT-7 may be considered to
have a threshold of carcinogenicity.
The no observed adverse effect level (NOAEL) for
carcinogenicity of MWNT-7 in this study was 0.02 mg/
m3 since exposure to this level of MWNT-7 did not
result in the development of lung carcinomas in male
rats. The chronic toxicity of MWNT-7, the low-
observed-adverse-effect level (LOAEL), was 0.02 mg/m3
since absolute and relative lung weights were signifi-
cantly elevated in female rats exposed to 0.02 mg/m3
MWNT-7.
Conclusions
There is clear evidence of MWNT-7 carcinogenicity in
male and female F344 rats exposed to MWNT-7 aero-
sol by inhalation for 104 weeks. Lung carcinomas were
significantly increased in male rats by exposure to 0.2
and 2 mg/m3 MWNT-7 and in female rats by exposure
to 2 mg/m3 MWNT-7. Combined adenoma and carcin-
oma in the lung were also significantly increased by ex-
posure of male rats to 0.2 and 2 mg/m3 MWNT-7 and
by exposure of female rats to 2 mg/m3 MWNT-7. Fi-
nally, pre-neoplastic epithelial lesions were also signifi-
cantly increased by exposure of male rats to 0.2 and
2 mg/m3 MWNT-7 and by exposure of female rats to
2 mg/m3 MWNT-7. The induction of carcinomas and
combined carcinomas and adenomas was dose-
dependent in male rats, and the induction of pre-
neoplastic epithelial lesions was dose-dependent in
both males and females.
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Induction of plural mesothelioma by exposure to
MWNT-7 was not observed in this study. However,
simple mesothelial hyperplasia and focal fibrosis in the
parietal pleura were found in rats exposed to 2 mg/m3
MWNT-7.
In the studies reported to date, including this one,
three factors stand out as crucial for induction of tumors
by exposure to MWNT-7: (1) length, (2) biopersistence,
and (3) quantity of fibers in the exposed tissue. One
likely factor in the lack of mesothelioma development in
the MWNT-7 exposed rats is the low number of
MWNT-7 fibers in the pleura: 1.38 × 109 and 10.4 × 109
fibers were found in the lungs of the 0.2 mg/m3
MWNT-7 exposed males and the 2 mg/m3 MWNT-7
exposed females, respectively, while only on the order of




The MWCNT (MWNT-7; Lot No. 080126 until 88 weeks,
Lot No. 071223 from 89 weeks) was purchased from
Hodogaya Chemical, Co. Ltd. (Tokyo, Japan). This
MWNT-7 was used without further purification or siev-
ing. According to Hodogaya Chemical, Co. Ltd, the
MWNT-7 fibers were generated using a floating chemical
vapor deposition (CVD) process with a carbon purity of >
99.6 % (No. 071223) and > 99.8 % (No. 080126), a nominal
average diameter of 40 to 90 nm, an aspect ratio of greater
than 100, and a surface area of 24–28 m2/g. We previously
reported our analysis of MWNT-7 using LA-ICP-MAS:
iron, chromium and nickel in MWNT-7 were 4400, 48,
and 17 ppm, respectively [58].
The length and width of bulk MWNT-7, the MWNT-7
in the inhalation chambers, and the MWNT-7 in the lungs
was measured using SEM at magnifications of × 5000
and × 10,000 in our institute. The lengths of 1000 and the
widths of 500 bulk MWNT-7 fibers were measured using a
curvimeter and scale loupe on enlarged SEM-photographs.
The lengths and widths of 200 MWNT-7 fibers collected
from the inhalation chambers and 200 MWNT-7 fibers
collected from the lungs at the end of the experimental
period were measured using the SEM’s image analysis soft-
ware. Bulk MWNT-7, lot No. 071223, fibers had an aver-
age width of 83.8 nm and length of 5.2 μm, with 45.1 % of
the tubules being longer than 5 μm. Bulk MWNT-7, lot
No. 080126, fibers had an average width of 90.7 nm and
length of 5.7 μm, with 48.7 % of the tubules being longer
than 5 μm. The MWNT-7 fibers collected from the
inhalation chamber had an average with of 92.9–98.2 nm
and length of 5.4–5.9 μm. The MWNT-7 fibers found in
the lung had an average width of 95.5–109.6 nm and
length of 5.8–5.9 μm.
Animals
We used two-hundred F344/DuCrlCrlj rats of each sex
purchased from Charles River Japan Inc. (Kanagawa,
Japan) at 4 weeks of age. The animals were quarantined
and acclimated for 2 weeks before the commencement
of the experiment (exposure started at 6 weeks of age).
The animals were divided by stratified randomization
into 4 body weight-matched groups of 50 rats of each
sex for exposure to 0, 0.02, 0.2, or 2 mg/m3 MWNT-7.
During the acclimation and exposure periods, rats were
housed individually in stainless-steel wire hanging cages
(150 W× 216 D × 176 H mm) placed in pyramid-shaped
stainless steel inhalation exposure chambers (10 m3 in
volume). Throughout the experimental period including
quarantine, acclimation, and exposure, all animals had
free access to sterilized water and gamma-irradiation-
sterilized commercial pellet diet (CRF-1, Oriental Yeast
Co. Ltd., Tokyo, Japan). Fluorescent lighting was con-
trolled automatically to give a 12-h light/dark cycle.
This study was conducted in accordance with the
Organisation for Economic Co-operation and Develop-
ment (OECD) Guideline for Testing of Chemicals 451
“Carcinogenicity Studies” (OECD, 2009) [23] and with
“Standards to be Observed by Testing Institutions”
Notification No. 76 of the Ministry of Labour, Japan, 1
September 1988 (amendment: Notification No. 13 of
the Ministry of Labour, Japan, 29 March 2000) and with
the OECD Principles of Good Laboratory Practice
(OECD, 1981) [59]. This study was approved by the
Animal Experiment Committee of the Japan Bioassay
Research Center. Animal care and was conducted in
accordance with the Guideline for proper conduct of
Animal Experiments (Science Council of Japan, 2006).
Environment in the inhalation chamber and MWNT-7
exposure design
Throughout the 104-week experimental period, the venti-
lation flow rate of the inhalation chamber was maintained
at 1.67 m3/min, corresponding to 10 changes/hour, and
the chamber temperature and humidity were set at 22 ±
2 °C and 50 ± 20 %. The inhalation chamber environmen-
tal parameters were monitored every minute with sensors
for airflow, temperature (Shimaden, Co. Ltd., Tokyo,
Japan), and humidity (NGK Spark Plug, Co., Ltd., Nagoya,
Japan).
Groups of 50 rats of each sex were exposed to
MWNT-7 aerosol for 104 weeks (6 h/day, 5 days/week)
at target concentrations of 0, 0.02, 0.2, or 2 mg/m3.
Our facility is large enough to accommodate the 400
animals used in this study, therefore all of the rats
were exposed at the same time. The MWNT-7 concen-
trations used in this inhalation exposure study were
decided on the basis of the results of our previous 13-
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week inhalation study using MWNT-7 concentrations
of 0, 0.2, 1, and 5 mg/m3 [22].
Aerosol generation and inhalation exposure to MWNT-7
The aerosol generation method (cyclone sieve method)
of Kasai et al. [20–22] was used to generate MWNT-7
aerosols. We have developed an aerosol generator that
dry-aerosolizes MWNT-7 with an upward spiraling air-
stream, classifies particles by gravitational and centrifu-
gal forces, limits particle size with a sieve, and provides
the inhalation chamber with a size-limited MWNT-7
aerosol (Additional file 1: Figure S1). The aerosol gen-
erator is composed of an aerosol generation and sieving
unit, a concentration control unit, ionizers (Keyence
Corporation, Tokyo, Japan), and a touch panel data re-
cording device for data collection. The aerosol gener-
ation and sieving unit consists a cylindrical container
with a partitioning sieve (Seishin, Co. Ltd., Tokyo,
Japan) and a solenoid impactor. The concentration con-
trol unit consists of an optical particle controller (OPC,
OPC-AP-600, Sibata Scientific Technology, Ltd., Tokyo,
Japan) and a dust feeder (Type FO, Funken Powtechs,
INC,Tokyo, Japan). The dust feeder introduces bulk-
MWNT-7 (Fig. 8) into the mid-portion of the cylin-
drical container. Clean air is aspirated from nine
diagonally-opened slits installed at the bottom of the
cylinder by utilizing ejector air with a flow rate of
100 L/minute as the driving force, so that an upward
spiraling airstream is continuously generated. Bulk
MWNT-7 is dispersed and aerosolized by collision of
the MWNT-7 with the high-speed upward spiraling air-
stream provided from the slits. Shear forces within the
cyclone as well as in the ejector also contribute to dis-
persion. Light MWNT-7 particles are carried to the top
of the cylindrical container, where a partitioning sieve
is located, riding on the upward spiraling airstream and
selectively passing through the pores of the sieve (53 μm).
Heavy MWNT-7 particles spiral around under the sieve,
agglomerate by the centrifugal force generated by the up-
ward spiraling airstream, and finally fall down into the col-
lection flask. Pulse vibration generated by a solenoid
impactor prevents MWNT-7 clogging of the partitioning
sieve pores. Ionizers are deployed to prevent adsorption
onto walls of the system’s components and to prevent
self-assembly of MWNT-7 aerosols.
Monitoring and regulation of MWNT-7 aerosol in the
inhalation chamber
Chamber atmosphere samples were taken from the ani-
mals’ breathing zone. Monitoring and regulation of
MWNT-7 aerosols in the inhalation exposure chambers
is described in detail by Kasai et al. [20–22]. Particle
concentrations of MWNT-7 in the chambers were mon-
itored in real-time with an optical particle controller
(OPC). The OPC data were collected every 10 s. The
mass-concentrations of MWNT-7 were determined
gravimetrically by collecting aerosols on Teflon-binder
filters for each target exposure concentration after 1, 3,
or 5 h of exposure once every 2 weeks throughout the
experimental period. The mass per particle (the K value)
was calculated based on the particle concentration data
(particles/m3) collected by the OPC and the gravimetric
results (mass/m3). Using this K-value, particle concentra-
tions were converted to mass-concentrations every
30 min for each group during the exposure periods. The
chamber MWNT-7 concentrations were held constant
by controlling the movement of the dust feeder using a
feedback loop from the OPC: when the chamber con-
centration rose above the upper limit of a designated
concentration range, the dust feeder stopped supplying
MWNT-7 aerosol to the sieving unit and when the
chamber concentration fell below the lower limit, the
Fig. 8 SEM images of bulk MWNT-7. The bulk MWNT-7 is composed primarily of large clumps of MWNT-7. The sizes of the aggregate are around
50 nm in diameter. While less, there are also individual and fibrous MWNT-7 s present in the bulk MWNT-7
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dust feeder resumed supplying MWNT-7 aerosol to the
sieving unit. The size distribution and morphology of
the MWNT-7 fibers was determined nine times over
the course of 13 weeks throughout the experimental
period. The size distribution of the fibers was ascer-
tained using a micro-orifice uniform deposit cascade
impactor (MOUDI) (Model 125B NanoMoudi-II, MSP,
Shoreview, MN, USA), and the morphology of the
fibers was examined by SEM (SU8000, Hitachi Ltd.,
Tokyo, Japan).
Clinical observations and urinary, hematological, and
blood biochemical analyses
The animals were observed daily for clinical signs and
mortality. Body weight and food consumption were mea-
sured once a week for the first 14 weeks and every 4 weeks
thereafter. Urinary parameters were measured in the last
week of the 104-week experimental period with Ames
Reagent Strips (Multistix, Siemens Healthcare Diagnostics,
Tokyo, Japan). At the terminal necropsy, blood was col-
lected for hematology and blood biochemistry from the
abdominal aorta under isoflurane anesthesia after over-
night fasting. The blood sample was analyzed with an
automatic blood cell analyzer (ADVIA120, Siemens
Healthcare Diagnostics Inc. Tarrytown, NY, USA) and an
automatic analyzer (Hitachi 7080, Hitachi, Ltd., Ibaraki,
Japan) for blood biochemistry.
Organ weights and macroscopic and microscopic
examinations
Organs, including the adrenal, testis, ovary, heart, lung
(except for lungs collected for BALF analysis), kidney,
spleen, liver and brain, were collected at the terminal
necropsy and weighed and examined for macroscopic
lesions. To avoid contamination of MWNT-7, animals
from each administration group were anatomized sep-
arately. After macroscopic examination the nasal cavity,
nasopharynx, larynx, trachea, lungs, bone marrow,
lymph nodes (including lung associated lymph nodes),
thymus, spleen, heart, tongue, salivary gland, esopha-
gus, stomach, small intestine, large intestine, liver, pan-
creas, kidneys, urinary bladder, pituitary gland, thyroid,
parathyroid, adrenal glands, testis, epididymis, seminal
vesicle, prostate, ovaries, uterus, vagina, mammary
gland, brain, spinal cord, peripheral nerve, olfactory
bulb, eye, Harderian gland, muscle, bone, and dia-
phragm (as a part of the parietal pleura) were examined
histopathologically. For histopathological examination,
the tissues were fixed in 10 % neutral buffered formalin
and embedded in paraffin. The right lung was directly
fixed by immersion. The left lung including the BALF
collected rats was inflated with fixative at a water pres-
sure of 20–25 cm, and then fixed by immersion. The
nasal cavity was decalcified in a formic acid-formalin
solution and then transversely trimmed at three levels as
previously described [21, 60]. Tissue sections of all organs,
including the right lung and left lung, of 5 μm in thickness
were prepared and stained with hematoxylin and eosin
(H & E) (Additional file 2: Table S1). To detect MWNT-7 s
deposited in the larynx, trachea, lungs, pleura (diaphragm),
lymph nodes, spleen, liver, kidneys, olfactory bulb, and
brain, sections were stained with Kernechtrot stain (Merck,
Darmstadt, Germany) for 1 min and washed with distilled
water for 5 min.
Cytological and biochemical analyses of the BALF
At the end of the experimental period, five animals from
each group were lavaged (Additional file 2: Table S1). The
right bronchus was tied with a thread in order to lavage
only the left lung. The lung was lavaged 2 times with 5 ml
Eagle’s Minimum Essential Medium (MEM, adjusted pH7.2
with 1 N NaOH and 15 mM HEPES without sodium
hydrogen carbonate) for males and 4 ml for females at a
water pressure of 20–25 cm (the epithelium is peeled by
washing with higher pressure or by washing more than
twice). The wash-out was collected for cytological and
biochemical analysis and the lung tissue was processed for
histopathological examination as described above. The
cells in the BALF were counted with an automatic cell
analyzer (Sysmex fully automated hematology analyzers
XT-2000iv). For biochemical analysis, the BALF was
centrifuged at 1960 rpm (800 g) at 4 °C for 10 min, and
aliquots of the acellular supernatant were examined with
an automatic analyzer (Hitachi 7080, Hitachi, Ltd., Ibaraki,
Japan). Total protein (TP), lactate dehydrogenase (LDH),
and alkaline phosphatase (ALP) levels were measured by
conventional biochemical methods. TP was chosen as an
indicator of alveolo-capillary permeability while LDH and
ALP were used as indicators of general cytotoxicity and
type II epithelial cell toxicity, respectively.
MWNT-7 lung burden
Lung burden analysis was determined for dead and
euthanized animals (Additional file 2: Table S1): 7, 7, and
6 males and 12, 8, and 11 females from the 0.02, 0.2, and
2 mg/m3 MWNT-7-exposed groups, respectively. At ter-
minal necropsy, lung burden was determined for 10
MWNT-7-exposed animals from each group (Additional
file 2: Table S1). Lungs were weighed and then prepared
for histopathological examination; remaining right lung
tissue (0.04–0.12 g) was used for lung burden analysis. For
determination of lung burden, lung tissue was digested ac-
cording to the method of Kohyama et al. [61], and filtered
to obtain dry specimens. MWNT-7 measurement was
performed according to the method of Ohnishi et al. [62].
Lung burden was determined as the MWNT-7 value in
the analyzed lung tissue multiplied by the ratio of total
lung weight/analyzed lung weight. The amounts of
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MWNT-7 per whole lung and per gram body weight
were determined. For determination of the number of
MWNT-7 fibers in the lung, one μg bulk MWNT-7
was suspended in 100 ml distilled water containing
0.1 % Tween 80 as a colloidal dispersant and subjected
to ultrasonication for 30 min with an ultrasonic
homogenizer (VP-30S, 20 kHz, 300 W, TAITEC Co.
Ltd, Tokyo, Japan). A polycarbonate membrane filter
(Isopore, Millipore, MA, USA) pre-coated with Pt for
electron charge avoidance was positioned on a suction
filtration apparatus, and 10 μl of the MWNT-7 suspen-
sion was placed on the filter and dried by suction. After
drying, an area equal to 1 % of whole filter was sub-
jected to field emission SEM. The MWNT-7 fibers on
the filter were photographed for counting at a magnifi-
cation of × 2000. The number of fibers in one-μg
MWNT-7 were calculated from the dilution ratio and
area ratio of the filter. The total number of MWNT-7
fibers in the lungs was calculated as the number of fi-
bers in one-μg of MWNT-7 multiplied by the μg of
MWNT-7 in the lung.
Observation of MWNT-7 in the lung
To observe MWNT-7 in the lung, lung tissues were
digested according to the method of Kohyama et al. [61].
The lung tissues were left for 5 days in the digestion
solution. The solution was then filtered and specimens
collected on polycarbonate membrane filters (Isopore,
Millipore, MA, USA) pre-coated with Pt for electron
charge avoidance. The specimens were observed by SEM.
Measurement of number MWNT-7 pleural and abdominal
lavage fluid
At terminal necropsy, the pleural cavity of ten animals
was lavaged once with 8 ml MEM, and the abdominal
cavity of ten other animals was lavaged once with 40 ml
MEM. The washout was collected and centrifuged at
12,000 rpm (3000 g) at 15 °C for 10 min. The supernatant
was removed and the pellet was digested according to the
method of Kohyama et al. [61]. A polycarbonate mem-
brane filter (Isopore, Millipore, MA, USA) pre-coated with
Pt for electron charge avoidance was positioned on a
suction filtration apparatus, and MWNT-7 fibers were
collected onto the filter. The morphology of the fibers was
determined by SEM examination, and the number of
MWNT-7 fibers was counted.
Statistics
Incidences of neoplastic lesions were analyzed for a dose
response relationships by Peto’s test [63] and for a signifi-
cant difference from the clean air-exposed group by
Fisher’s exact test. Incidences of non-neoplastic lesions
and urinary parameters were analyzed by the Chi-square
test. Survival curves were plotted according to the method
of Kaplan-Meier [64], and the log-rank test [65] was used
to detect statistically significant differences in survival
rates between any MWNT-7 exposed groups of either sex
and the clean air-exposed group. Body weight, organ
weight, food consumption, hematology, blood biochemical
parameters, and biochemical and cytological parameters
in the BALF were analyzed by Dunnett’s multiple com-
parison test. Two-tailed tests were used for all statistical
analyses except for Peto’s test. P values less than 0.05 were
considered to be statistically significant.
Additional files
Additional file 1: Figure S1. Blue arrows indicate the flow of the
MWNT-7. Red arrows indicate aerosolization of the MWNT-7 by the up-
ward spiraling airstream. MWNT-7 (Bulk MWNT-7) is first placed into the
dust feeder. The dust feeder transports a portion of the MWNT-7 into the
sieving chamber (Left panel). In the sieving chamber, clean air is aspirated
from 9 diagonally opened slits by using the ejector air as the driving
force, so that an upward spiraling airstream is continuously generated in
the cylindrical sieving chamber. MWNT-7 is dispersed and aerosolized by
the high-speed spiraling air. Light MWNT-7 particles are carried to the
top of the sieving chamber, where a partitioning sieve is located. Only
the sieved MWNT-7 can be delivered to the inhalation chamber. Ionizers
are used to avoid agglomeration. This equipment has a feedback system
for keeping the aerosol concentration in the inhalation chamber constant.
(PPS 2292 kb)
Additional file 2: Table S1. Number of Rats Examined for Lung
Histopathology, BALF and Lung Burden. (XLSX 13 kb)
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